• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number S-50-100-120-P6
Device Problems Difficult to Remove (1528); Material Separation (1562); Improper or Incorrect Procedure or Method (2017); Failure to Advance (2524)
Patient Problem Vessel Or Plaque, Device Embedded In (1204)
Event Date 08/12/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was performed to treat a heavily calcified lesion in the superficial femoral artery.Following pre-dilatation with an unspecified balloon catheter, scoring balloon and atherectomy, a 5.0x100mm supera self-expanding stent was deployed.An attempt to remove the delivery catheter under fluoroscopy was made; however, resistance with the calcium in the vessel was felt.Additionally, the deployment and system locks were not locked before attempting to remove the delivery system and the nose cone separated.The nose cone could not be retrieved and it was embedded in the popliteal artery by ballooning it into the calcium.The nose cone is not moving and the physician will continue to monitor the patient.A clinically significant delay in the procedure was reported.No additional information was provided.
 
Manufacturer Narrative
Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for evaluation.Therefore, is was unable to confirm the reported separation of nose cone as well as the reported difficulty to remove.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this event.Furthermore, a review of the complaint history did not indicate a lot specific issue.It should be noted in the supera self-expanding stent system instructions for use states: following confirmed implantation of the supera stent, retract the thumb slide in a single motion to the starting position on the handle and rotate the system lock and deployment lock into a locked position, in line with the thumb slide.In this case, failing to the retract the thumbslide to the starting position prior to removal likely contributed to the nose cone separation.The investigation determined the difficulties appear to be related to challenging anatomical conditions.Circumstances of the procedure dictate that reported tip separation weighs heavily on the device meeting resistance with the calcified lesion during removal.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.It was initially reported that the device would be returned for analysis.Subsequent information revealed that the device was discarded and is not available for evaluation.Device code 2524 was removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA PERIPHERAL STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key8952497
MDR Text Key156665958
Report Number2024168-2019-11367
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648211768
UDI-Public08717648211768
Combination Product (y/n)N
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 11/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/30/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2020
Device Catalogue NumberS-50-100-120-P6
Device Lot Number8062161
Was Device Available for Evaluation? No
Date Manufacturer Received11/08/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SHEATH: 6F
Patient Outcome(s) Required Intervention;
Patient Age95 YR
Patient Weight68
-
-